Historical award
Essential Access Health
This record is historical buying context, not open work.
How current is this award history?
Fiscal year 2025: data through (11 days old).
Fiscal year 2026: data through (11 days old).
Official release availability details
Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
- Current award value
- $1,420,018.61
- Potential award value
- $1,420,018.61
- Total obligated to date
- $1,420,018.61
Source date: Nov 9, 2026
Recorded work
A MULTI-CENTER, RANDOMIZED STUDY TO EVALUATE THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE, CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL LOW DOSE ULIPRISTAL ACETATE
Award activity
- Obligations in covered fiscal years
- −$5,655.39
- Transactions in covered fiscal years
- 1
Award value and obligated funds describe different amounts. Review the official record for the full transaction history.
Record identifier
CONT_AWD_HHSN27500002_7529_HHSN275201300022I_7529